Skip to main content

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.  

A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz

About Carlsmed, Inc.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
Caroline Corner, PhD
IR@Carlsmed.com 

Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.57
+2.30 (1.10%)
AAPL  255.63
+1.84 (0.73%)
AMD  210.21
+6.78 (3.33%)
BAC  49.27
+0.52 (1.07%)
GOOG  294.90
+8.04 (2.80%)
META  579.23
+7.10 (1.24%)
MSFT  369.37
-0.80 (-0.22%)
NVDA  175.75
+1.35 (0.77%)
ORCL  145.23
-1.88 (-1.28%)
TSLA  381.26
+9.51 (2.56%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.